1350 related articles for article (PubMed ID: 16764116)
1. Research interactions between industry and academia: a corporate perspective.
Citron P
Physiologist; 1996 Jun; 39(3):81, 90-2. PubMed ID: 16764116
[No Abstract] [Full Text] [Related]
2. Principles, property rights, and profits: historical reflections on university/industry relations.
Kevles DJ
Account Res; 2001; 8(4):293-307. PubMed ID: 12481797
[No Abstract] [Full Text] [Related]
3. Cementing links between industry and the university.
Jennings R
Nat Biotechnol; 1998 May; 16 Suppl():35-6. PubMed ID: 9591263
[No Abstract] [Full Text] [Related]
4. Surprise US election results may boost biotech.
Fox JL
Nat Biotechnol; 2002 Dec; 20(12):1176. PubMed ID: 12454655
[No Abstract] [Full Text] [Related]
5. Intellectual property issues in a clinical trial: a corporate perspective.
Fersko RS; Connolly MJ
Qual Assur; 1992 Jun; 1(3):237-48. PubMed ID: 1344679
[No Abstract] [Full Text] [Related]
6. The NIH, research institutions and industry: working together on a shared goal.
Omary MB
Gastroenterology; 2007 May; 132(5):1647-50. PubMed ID: 17484859
[No Abstract] [Full Text] [Related]
7. Grant proposal reviewer says he would have scored proposal lower due to conflict of interest.
Maloney DM
Hum Res Rep; 2004 Dec; 19(12):8. PubMed ID: 15810180
[No Abstract] [Full Text] [Related]
8. Researcher said his colleague should have revealed possible conflicts of interest.
Maloney DM
Hum Res Rep; 2005 Jan; 20(1):8. PubMed ID: 15810184
[No Abstract] [Full Text] [Related]
9. Industry and academia in transition.
Kennedy D
Science; 2003 Nov; 302(5649):1293. PubMed ID: 14631000
[No Abstract] [Full Text] [Related]
10. Financial conflicts of interest in biomedical research: the need to improve the system.
Wang AT; Montori VM; Murad MH
Drug News Perspect; 2010 Nov; 23(9):607-12. PubMed ID: 21152455
[TBL] [Abstract][Full Text] [Related]
11. Companies balk at California's patent rules for stem cell research.
Keim B
Nat Med; 2007 Jan; 13(1):6. PubMed ID: 17206112
[No Abstract] [Full Text] [Related]
12. Intellectual property and biotechnology: the U.S. internal experience--Part II.
Brody B
Kennedy Inst Ethics J; 2006 Jun; 16(2):105-28. PubMed ID: 17036443
[TBL] [Abstract][Full Text] [Related]
13. The search for a cure: combating the problem of conflicts of interest that currently plagues biomedical research.
Clamon JB
Iowa Law Rev; 2003 Oct; 89(1):235-71. PubMed ID: 15732180
[No Abstract] [Full Text] [Related]
14. [Patent rights and the free research. The boundary between basic research and private sector is not longer razor-sharp].
Westerlund L
Lakartidningen; 2005 Sep 26-Oct 2; 102(39):2737. PubMed ID: 16245544
[No Abstract] [Full Text] [Related]
15. Biobusiness on campus: commercialization of university-developed biomedical technologies.
Dueker KS
Food Drug Law J; 1997; 52(4):453-509. PubMed ID: 10346675
[No Abstract] [Full Text] [Related]
16. Razing the tollbooths. A call for restricting patents on basic biomedical research.
Stix G
Sci Am; 2003 Apr; 288(4):37. PubMed ID: 12661312
[No Abstract] [Full Text] [Related]
17. Ethical implications of for-profit corporate sponsorship of research.
Cichy KA
SRA J; 1990; 22(1):23-7. PubMed ID: 16047436
[TBL] [Abstract][Full Text] [Related]
18. Taking knowledge from bench to bank.
Horton B; Wickware P; Gershon D; Gavaghan H
Nature; 1998 Sep; 395(6700):409-14. PubMed ID: 9759734
[No Abstract] [Full Text] [Related]
19. Bayh-Dole: if we knew then what we know now.
Boettiger S; Bennett AB
Nat Biotechnol; 2006 Mar; 24(3):320-3. PubMed ID: 16525405
[No Abstract] [Full Text] [Related]
20. The interface between publicly funded and industry-funded research in pediatric psychopharmacology: opportunities for integration and collaboration.
Vitiello B; Heiligenstein JH; Riddle MA; Greenhill LL; Fegert JM
Biol Psychiatry; 2004 Jul; 56(1):3-9. PubMed ID: 15219466
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
